Hydrocodone Polistirex and Chlorpheniramine Polistirex
These highlights do not include all the information needed to use Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension safely and effectively. See full prescribing information for Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Oral Suspension. Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, for oral administration, CII Initial U.S. Approval: 1987
25f400d9-1d6e-4d38-8f0d-98d471eba73b
HUMAN PRESCRIPTION DRUG LABEL
May 31, 2021
Tris Pharma Inc
DUNS: 947472119
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Hydrocodone Polistirex and Chlorpheniramine Polistirex
Product Details
FDA regulatory identification and product classification information